NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]
Argus downgrades Zimmer Biomet
Declining sales and the supply & manufacturing issues that have bedeviled Zimmer Biomet (NYSE:ZBH) recently prompted an Argus analyst to downgrade the orthopedic giant’s stock today. Argus analyst David Toung moved ZBH shares from a “buy” to a “hold” rating based on the company’s estimate that it would be the second quarter before it returned to full […]
Zimmer Biomet ends BoneSupport Cerament BVF distribution deal
BoneSupport said today that its US exclusive distributor Zimmer Biomet (NYSE:ZBH) has cancelled the majority of its orders for Cerament bone void filler for a three month period starting in June. The move comes after the Sweden-based orthobiologic producer announced plans to develop its own US-based distribution network, which includes cancelling its distribution agreement with Zimmer Biomet. “Today’s […]
FDA clears Zimmer Biomet’s 3D-printed titanium Zyston spinal implant
Zimmer Biomet (NYSE:ZBH) said yesterday it won FDA 510(k) clearance for its Zyston Strut open titanium interbody spacer system, touting it as the company’s first 3D-printed titanium spinal implant. The Zyston Strut open titanium system is a family of lumbar cages intended to enhance strength, graft capacity and visualization capabilities of interbody spacers in spinal fusion […]
Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat
Stryker‘s (NYSE:SYK) Homedica is on the hook for approximately $13.3 million in attorney’s fees and $513,258 in costs due to Zimmer Biomet (NYSE:ZBH) as a result of a patent dispute, according to recently unsealed court documents. The award is the result of a long-running patent spat over polymers between the two companies that ended in four […]
Physician released from Biomet metal-on-metal hip suit
A physician and metal-on-metal hip replacement designer was released from litigation against them and Biomet, now part of Zimmer Biomet (NYSE:ZBH), over issues with jurisdiction, according to court documents posted last week. US Judge Robert Miller Jr. of the US District Court for the Northern District of Indiana South Bend Division dismissed the case against Dr. […]
Zimmer Biomet to debut robotics solutions
Zimmer Biomet (NYSE:ZBH) today revealed plans to unveil its robotics solutions for orthopedic and neurosurgeries this week at the annual meeting of the American Assn. of Neurological Surgeons in New Orleans. The Warsaw, Ind.-based company said it plans to showcase two elements of its Surgery Assisting Technology suite: the WalterLorenz surgical assist arm and the Rosa Brain […]
Zimmer Biomet’s Q1 beats The Street despite profit slide
Zimmer Biomet (NYSE:ZBH) beat both the consensus forecast and its own guidance with its first-quarter results despite a more than 40% profit slide. The Warsaw, Ind.-based orthopedics giant posted profits of $174.7 million, or 85¢ per share, on sales of $2.02 billion for the three months ended March 31, for a bottom-line slide of -41.6% on […]
Zimmer Biomet wins FDA nod, launches Persona trabecular metal tibia
Zimmer Biomet (NYSE:ZBH) said yesterday it launched its Persona Trabecular metal tibia system, which won FDA clearance in January, and added that the device was used in its first commercial procedure. The Persona Trabecular metal tibia was used in a procedure performed by Dr. Richard Moore of Boise, Idaho, the Warsaw, Ind.-based company said. “The clearance […]
Zimmer Biomet launches FDA-cleared Comprehensive augmented baseplate
Zimmer Biomet (NYSE:ZBH) said today it launched the Comprehensive Augmented baseplate component designed for its Comprehensive reverse shoulder system, having won FDA approval in January this year. The Warsaw, Ind.-based company said that the device had been used in its first shoulder procedure, performed by Dr. John Sperling of the Mayo Clinic. Zimmer Biomet said that […]
Zimmer Biomet touts 7-year results in Mobi-C cervical disc trial
Zimmer Biomet (NYSE:ZBH) yesterday released seven-year follow-up results from a study of its Mobi-C cervical disc device designed for total disc replacement procedures, touting lower pain, maintained motion range and other benefits. Results from the study were published in the International Journal of Spine Surgery, the Warsaw, Ind.-based company said. In the study, researchers compared the […]
- 1
- 2
- 3
- …
- 33
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+